Literature DB >> 20471392

Uridine triphosphate (UTP) induces profibrotic responses in cardiac fibroblasts by activation of P2Y2 receptors.

Oscar O Braun1, David Lu, Nakon Aroonsakool, Paul A Insel.   

Abstract

Cardiac fibroblasts (CFs) play a key role in response to injury and remodeling of the heart. Nucleotide (P2) receptors regulate the heart but limited information is available regarding such receptors in CFs. We thus sought to determine if extracellular nucleotides regulate fibrotic responses (e.g., proliferation, migration and expression of profibrotic markers) of CFs in primary culture. UTP increased rat CF migration 3-fold (p<0.001), proliferation by 30% (p<0.05) and mRNA expression of profibrotic markers: alpha smooth muscle actin (alpha-SMA), plasminogen activator inhibitor-1 (PAI-1), transforming growth factor beta, soluble ST2, interleukin-6 and monocyte chemoattractant protein-1 (MCP-1) by 3.0-, 15-, 2.0-, 7.6-, 11-, and 6.1-fold, respectively (p<0.05). PAI-1 protein expression induced by UTP was dependent on protein kinase C (PKC) and extracellular signal-regulated kinase (ERK), based on blockade by the PKC inhibitor Ro-31-8220 and the ERK inhibitor U0126, respectively. The rank order for enhanced expression of PAI-1 and alpha-SMA by nucleotides (UTPgammaS>>UDPbetaS>>ATPgammaS), the expression of P2Y2 receptors as the most abundantly expressed P2Y receptor in rat CFs and a blunted response to UTP in P2Y2(-/-) mice all implicate P2Y2 as the predominant P2Y receptor that mediates nucleotide-promoted profibrotic responses. Additional results indicate that P2Y2 receptor-promoted profibrotic responses in CFs are transient, perhaps as a consequence of receptor desensitization. We conclude that P2Y2 receptor activation is profibrotic in CFs; thus inhibition of P2Y2 receptors may provide a novel means to diminish fibrotic remodeling and turnover of extracellular matrix in the heart. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20471392      PMCID: PMC2917486          DOI: 10.1016/j.yjmcc.2010.05.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  49 in total

Review 1.  Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia.

Authors:  Razi Khan; Richard Sheppard
Journal:  Immunology       Date:  2006-05       Impact factor: 7.397

Review 2.  Structural and functional characterisation of cardiac fibroblasts.

Authors:  Patrizia Camelliti; Thomas K Borg; Peter Kohl
Journal:  Cardiovasc Res       Date:  2005-01-01       Impact factor: 10.787

3.  Extracellular nucleotides induce migration of renal mesangial cells by upregulating sphingosine kinase-1 expression and activity.

Authors:  S Klawitter; L P Hofmann; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-01-02       Impact factor: 8.739

4.  2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.

Authors:  Mariell Jessup; William T Abraham; Donald E Casey; Arthur M Feldman; Gary S Francis; Theodore G Ganiats; Marvin A Konstam; Donna M Mancini; Peter S Rahko; Marc A Silver; Lynne Warner Stevenson; Clyde W Yancy
Journal:  Circulation       Date:  2009-03-26       Impact factor: 29.690

5.  Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors.

Authors:  Johanna Balogh; Anna-Karin Wihlborg; Henrik Isackson; Bhalchandra V Joshi; Kenneth A Jacobson; Anders Arner; David Erlinge
Journal:  J Mol Cell Cardiol       Date:  2005-08       Impact factor: 5.000

6.  The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy.

Authors:  David J Friedman; Helmut G Rennke; Eva Csizmadia; Keiichi Enjyoji; Simon C Robson
Journal:  Diabetes       Date:  2007-05-01       Impact factor: 9.461

7.  Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor.

Authors:  Evgenia V Gerasimovskaya; Shama Ahmad; Carl W White; Peter L Jones; Todd C Carpenter; Kurt R Stenmark
Journal:  J Biol Chem       Date:  2002-09-18       Impact factor: 5.157

8.  Mitogenic effects of ATP on vascular smooth muscle cells vs. other growth factors and sympathetic cotransmitters.

Authors:  D Erlinge; H Yoo; L Edvinsson; D J Reis; C Wahlestedt
Journal:  Am J Physiol       Date:  1993-10

9.  UTP transactivates epidermal growth factor receptors and promotes cardiomyocyte hypertrophy despite inhibiting transcription of the hypertrophic marker gene, atrial natriuretic peptide.

Authors:  James B Morris; Tam M Pham; Bronywn Kenney; Karen E Sheppard; Elizabeth A Woodcock
Journal:  J Biol Chem       Date:  2003-12-14       Impact factor: 5.157

10.  The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals.

Authors:  Utako Yokoyama; Hemal H Patel; N Chin Lai; Nakon Aroonsakool; David M Roth; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

View more
  20 in total

Review 1.  New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors.

Authors:  Ross Corriden; Paul A Insel
Journal:  Purinergic Signal       Date:  2012-04-15       Impact factor: 3.765

2.  ATP released from cardiac fibroblasts via connexin hemichannels activates profibrotic P2Y2 receptors.

Authors:  David Lu; Sahar Soleymani; Rohit Madakshire; Paul A Insel
Journal:  FASEB J       Date:  2012-03-13       Impact factor: 5.191

Review 3.  Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosis.

Authors:  David Lu; Paul A Insel
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-18       Impact factor: 4.249

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolase (ENTPD) establishes the set point for fibrotic activity of cardiac fibroblasts.

Authors:  David Lu; Paul A Insel
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

6.  Vascular endothelial growth factor-D mediates fibrogenic response in myofibroblasts.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Syamal K Bhattacharya; Yao Sun
Journal:  Mol Cell Biochem       Date:  2016-01-02       Impact factor: 3.396

7.  Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB.

Authors:  Motohiro Nishida; Mariko Ogushi; Reiko Suda; Miyuki Toyotaka; Shota Saiki; Naoyuki Kitajima; Michio Nakaya; Kyeong-Man Kim; Tomomi Ide; Yoji Sato; Kazuhide Inoue; Hitoshi Kurose
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

8.  Adenosine-5'-triphosphate up-regulates proliferation of human cardiac fibroblasts.

Authors:  Jing-Bo Chen; Wen-Juan Liu; Hui Che; Jie Liu; Hai-Ying Sun; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

9.  Targeted Disruption of Ig-Hepta/Gpr116 Causes Emphysema-like Symptoms That Are Associated with Alveolar Macrophage Activation.

Authors:  Donna Maretta Ariestanti; Hikaru Ando; Shigehisa Hirose; Nobuhiro Nakamura
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

10.  Impaired UTP-induced relaxation in the carotid arteries of spontaneously hypertensive rats.

Authors:  Takayuki Matsumoto; Mihoka Kojima; Keisuke Takayanagi; Tomoki Katome; Kumiko Taguchi; Tsuneo Kobayashi
Journal:  Purinergic Signal       Date:  2020-08-29       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.